Mi Yon Shim

Introduction: Mi Yon Shim is a distinguished inventor based in Yongin-si, South Korea. He is renowned for his contributions to pharmacology, particularly in the development of innovative therapeutic agents targeting pain modulation.

Latest Patents: One of Mi Yon Shim's notable patents is the "Dual modulator of mGluR5 and 5-HT2A receptor, and use thereof." This patent discloses a unique compound that serves as a dual modulator of mGluR5 while simultaneously acting as an antagonist of the 5-HT2A receptor. The innovative use of this compound opens avenues for its application as a therapeutic agent for pain, showcasing its significance in the medical field.

Career Highlights: Currently, Mi Yon Shim is associated with Vivozon, Inc., where he applies his expertise to advance research in drug development. His work transcends conventional approaches, reflecting his commitment to creating impactful solutions in healthcare.

Collaborations: Throughout his career, Mi Yon Shim has collaborated with esteemed colleagues, including Dae Kyu Choi and Hyo Jin Kim. Their collective efforts contribute to a dynamic research environment, fostering the innovation of next-generation therapies.

Conclusion: Mi Yon Shim exemplifies the spirit of innovation through his contributions to pain management therapeutics. With a notable patent and an active role in Vivozon, Inc., he continues to pave the way for advancements in the medical field, demonstrating the importance of interdisciplinary collaboration in achieving revolutionary breakthroughs.

Profile summary based on public USPTO records.